Mother with rare ALS touts 'miracle drug' that has stopped her disease
Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a ...
Rolling Out24d
Failed ALS trials reveal major medical breakthrough
When the results of the first-ever platform trial for amyotrophic lateral sclerosis (ALS) were published this February, the headlines might have seemed disappointing: four experimental drugs ...
ALS drug failures and why COYA 302 is different
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...
pharmaphorum4d
Four more drugs in keenly watched ALS trial miss the mark
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 HEALEY ALS basket trial, which is trying to accelerate the search for ...
ALS News Today14d
Woolsey secures additional funding to advance ALS therapy Bravyl
Woolsey Pharmaceuticals has secured additional funds to continue advancing its ROCK inhibitor Bravyl (oral fasudil) for the ...
WINK NEWS1mon
Breakthrough for patients diagnosed with ALS
“That’s when they were actually looking for the biomarkers so that they could develop the treatment,” said Sifford. The drug is the first of its kind for ALS. It targets the SOD-1 ...
New York Post3d
Mother with rare ALS touts ‘miracle drug’ that has stopped her disease
Raziel Green / Fox News Dr. Thomas Purvis, a neurologist at the West Virginia University Rockefeller Neuroscience Institute, called tofersen one of the “most exciting medications” for ALS in ...